Since 2005, Shohei Kobayashi has been working on therapeutic antibody purification process development in Chugai Pharmaceutical Co., Ltd.. He worked in Roche Germany between 2016 to 2017, and contributed to joint process development and technology development. Now he is leading the Chugai’s pipeline process development, validation, technology transfer and viral safety as a head of purification process development group in API Process Development Dept..